560 related articles for article (PubMed ID: 21982497)
1. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
[TBL] [Abstract][Full Text] [Related]
2. NRPS substrate promiscuity leads to more potent antitubercular sansanmycin analogues.
Xie Y; Cai Q; Ren H; Wang L; Xu H; Hong B; Wu L; Chen R
J Nat Prod; 2014 Jul; 77(7):1744-8. PubMed ID: 24964393
[TBL] [Abstract][Full Text] [Related]
3. Rescrutiny of the sansanmycin biosynthetic gene cluster leads to the discovery of a novel sansanmycin analogue with more potency against Mycobacterium tuberculosis.
Shi Y; Wang X; He N; Xie Y; Hong B
J Antibiot (Tokyo); 2019 Oct; 72(10):769-774. PubMed ID: 31341273
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents.
Hirano S; Ichikawa S; Matsuda A
Bioorg Med Chem; 2008 May; 16(9):5123-33. PubMed ID: 18375127
[TBL] [Abstract][Full Text] [Related]
5. A new nucleosidyl-peptide antibiotic, sansanmycin.
Xie Y; Chen R; Si S; Sun C; Xu H
J Antibiot (Tokyo); 2007 Feb; 60(2):158-61. PubMed ID: 17420567
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
7. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
9. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
Dinakaran M; Senthilkumar P; Yogeeswari P; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):11-8. PubMed ID: 18078735
[TBL] [Abstract][Full Text] [Related]
10. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents.
Alegaon SG; Alagawadi KR; Sonkusare PV; Chaudhary SM; Dadwe DH; Shah AS
Bioorg Med Chem Lett; 2012 Mar; 22(5):1917-21. PubMed ID: 22325950
[TBL] [Abstract][Full Text] [Related]
11. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
12. Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones.
Kamal A; Shetti RV; Azeeza S; Swapna P; Khan MN; Khan IA; Sharma S; Abdullah ST
Eur J Med Chem; 2011 Mar; 46(3):893-900. PubMed ID: 21272965
[TBL] [Abstract][Full Text] [Related]
13. Sansanmycins B and C, new components of sansanmycins.
Xie Y; Xu H; Si S; Sun C; Chen R
J Antibiot (Tokyo); 2008 Apr; 61(4):237-40. PubMed ID: 18503203
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimycobacterial evaluation of novel 5,6-dimethoxy-1-oxo-2,5-dihydro-1H-2-indenyl-5,4-substituted phenyl methanone analogues.
Ali MA; Samy JG; Manogaran E; Sellappan V; Hasan MZ; Ahsan MJ; Pandian S; ShaharYar M
Bioorg Med Chem Lett; 2009 Dec; 19(24):7000-2. PubMed ID: 19879757
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
[TBL] [Abstract][Full Text] [Related]
18. Improving the N-terminal diversity of sansanmycin through mutasynthesis.
Shi Y; Jiang Z; Lei X; Zhang N; Cai Q; Li Q; Wang L; Si S; Xie Y; Hong B
Microb Cell Fact; 2016 May; 15():77. PubMed ID: 27154005
[TBL] [Abstract][Full Text] [Related]
19. Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity.
Changtam C; Hongmanee P; Suksamrarn A
Eur J Med Chem; 2010 Oct; 45(10):4446-57. PubMed ID: 20691508
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
Ahsan MJ; Samy JG; Jain CB; Dutt KR; Khalilullah H; Nomani MS
Bioorg Med Chem Lett; 2012 Jan; 22(2):969-72. PubMed ID: 22197387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
